Clinical Trial: A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors

U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538648) titled 'A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors' on April 13.

Brief Summary: Evaluate the initial dose-effect and time-effect relationship of the injection product NC527-X

Study Start Date: Dec. 24, 2025

Study Type: INTERVENTIONAL

Condition: Cancer

Intervention: DRUG: Experimental:Preoperative injection of NC527-X

This study will set up four single-arm dose groups (A, B, C, D), and it will be conducted in patients with solid tumors who have been diagnosed and are scheduled for surgical resection (evaluated by the researchers to have no surg...